{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:52:40Z","timestamp":1793083960203,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04021-4","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:11:21Z","timestamp":1747199481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antimicrobial susceptibility at intensive care units in Sudan, antibiogram development"],"prefix":"10.1186","volume":"25","author":[{"given":"Ghada Omer Hamad","family":"Abd El-Raheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Elhadi Ahmed","family":"Dihesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Elmutaz Babikir","family":"Elmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana Eltayeb Salih","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa Elsir Abas","family":"Zeinelabdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Omer Suliman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa Abdelmajid Alhaj","family":"Mudather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omema Abdelkrem Abdelftah","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanadie Mustafa Ebrahim","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"4021_CR1","doi-asserted-by":"publisher","unstructured":"Pereckaite L, Tatarunas V, Giedraitiene A. Current antimicrobial susceptibility testing for beta-lactamase-producing Enterobacteriaceae in clinical settings. J Microbiol Methods. 2018;152:154\u2013164. https:\/\/doi.org\/10.1016\/j.mimet.2018.07.014. Epub 2018 Jul 29. PMID: 30063958.","DOI":"10.1016\/j.mimet.2018.07.014"},{"key":"4021_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jgar.2021.08.001","volume":"27","author":"I Samreen, Ahmad","year":"2021","unstructured":"Samreen, Ahmad I, Malak HA, Abulreesh HH. Environmental antimicrobial resistance and its drivers: a potential threat to public health. J Glob Antimicrob Resist. 2021;27:101\u201311. https:\/\/doi.org\/10.1016\/j.jgar.2021.08.001. Epub 2021 Aug 25. PMID: 34454098.","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"4021_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.mcna.2018.04.005","volume":"102","author":"EJ Septimus","year":"2018","unstructured":"Septimus EJ. Antimicrobial resistance: an antimicrobial\/Diagnostic stewardship and infection prevention approach. Med Clin North Am. 2018;102(5):819\u201329. https:\/\/doi.org\/10.1016\/j.mcna.2018.04.005. Epub 2018 Jun 27. PMID: 30126573.","journal-title":"Med Clin North Am"},{"key":"4021_CR4","doi-asserted-by":"publisher","unstructured":"Rajasekar SJS, Thiyagarajan S, Mohamed Ali S. Ab.ai - A Novel Automated AI Tool for Reporting Antibiograms. Stud Health Technol Inform. 2022;299:202\u2013207. https:\/\/doi.org\/10.3233\/SHTI220984. PMID: 36325864.","DOI":"10.3233\/SHTI220984"},{"issue":"4","key":"4021_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.giec.2020.06.004","volume":"30","author":"L Morrison","year":"2020","unstructured":"Morrison L, Zembower TR. Antimicrobial resistance. Gastrointest Endosc Clin N Am. 2020;30(4):619\u201335. https:\/\/doi.org\/10.1016\/j.giec.2020.06.004. Epub 2020 Aug 1. PMID: 32891221.","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"1","key":"4021_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1186\/s12879-021-06795-0","volume":"21","author":"DK Saeed","year":"2021","unstructured":"Saeed DK, Farooqi J, Shakoor S, Hasan R. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006\u20132018. BMC Infect Dis. 2021;21(1):1231. https:\/\/doi.org\/10.1186\/s12879-021-06795-0. PMID: 34876041; PMCID: PMC8650393.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4021_CR7","doi-asserted-by":"publisher","first-page":"e0183121","DOI":"10.1128\/aac.01831-21","volume":"66","author":"U Liebchen","year":"2022","unstructured":"Liebchen U, Weinelt F, Scharf C, Schroeder I, Paal M, Zoller M, Kloft C, Jung J, Michelet R. Combination of Pharmacokinetic and pathogen susceptibility information to optimize meropenem treatment of Gram-Negative infections in critically ill patients. Antimicrob Agents Chemother. 2022;66(2):e0183121. Epub 2021 Dec 6. PMID: 34871092; PMCID: PMC8846453.","journal-title":"Antimicrob Agents Chemother"},{"key":"4021_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jgar.2018.05.017","volume":"15","author":"SH Lob","year":"2018","unstructured":"Lob SH, Hoban DJ, Young K, Motyl MR, Sahm DF. Activity of Imipenem\/relebactam against Gram-negative bacilli from global ICU and non-ICU wards: SMART 2015\u20132016. J Glob Antimicrob Resist. 2018;15:12\u20139. https:\/\/doi.org\/10.1016\/j.jgar.2018.05.017. Epub 2018 May 29. PMID: 29857057.","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"4021_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12879-018-3494-x","volume":"18","author":"L Liu","year":"2018","unstructured":"Liu L, Ni Y. Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections. BMC Infect Dis. 2018;18(1):584. https:\/\/doi.org\/10.1186\/s12879-018-3494-x. PMID: 30453893; PMCID: PMC6245934.","journal-title":"BMC Infect Dis"},{"key":"4021_CR10","doi-asserted-by":"publisher","first-page":"e20180498","DOI":"10.1590\/0037-8682-0498-2018","volume":"53","author":"\u00c1CDS Ribeiro","year":"2019","unstructured":"Ribeiro \u00c1CDS, Crozatti MTL, Silva AAD, Macedo RS, Machado AMO, Silva ATA. Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption. Rev Soc Bras Med Trop. 2019;53:e20180498. https:\/\/doi.org\/10.1590\/0037-8682-0498-2018. PMID: 31859938; PMCID: PMC7083346.","journal-title":"Rev Soc Bras Med Trop"},{"key":"4021_CR11","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez J, Vazquez F. The Importance of Cumulative Antibiograms in Diagnostic Stewardship. Clin Infect Dis. 2019;69(6):1086\u20131087. https:\/\/doi.org\/10.1093\/cid\/ciz082. PMID: 30715204.","DOI":"10.1093\/cid\/ciz082"},{"issue":"1","key":"4021_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41467-021-21187-3","volume":"12","author":"M Pascucci","year":"2021","unstructured":"Pascucci M, Royer G, Adamek J, Asmar MA, Aristizabal D, Blanche L, Bezzarga A, Boniface-Chang G, Brunner A, Curel C, Dulac-Arnold G, Fakhri RM, Malou N, Nordon C, Runge V, Samson F, Sebastian E, Soukieh D, Vert JP, Ambroise C, Madoui MA. AI-based mobile application to fight antibiotic resistance. Nat Commun. 2021;12(1):1173. https:\/\/doi.org\/10.1038\/s41467-021-21187-3. PMID: 33608509; PMCID: PMC7895972.","journal-title":"Nat Commun"},{"issue":"8","key":"4021_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1017\/ice.2019.112","volume":"40","author":"SK Fridkin","year":"2019","unstructured":"Fridkin SK, Pack J, Licitra G, Zheng Z, Watkins R, Price S, Camp M, Moore R. Creating reasonable antibiograms for antibiotic stewardship programs in nursing homes: analysis of 260 facilities in a large geographic region, 2016\u20132017. Infect Control Hosp Epidemiol. 2019;40(8):839\u201346. Epub 2019 May 28. PMID: 31133088.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4021_CR14","doi-asserted-by":"crossref","unstructured":"Lanckohr C, Bracht H. Antimicrobial stewardship. Curr Opin Crit Care. 2022;28(5):551\u2013556. doi: 10.1097\/MCC.0000000000000967. Epub 2022 Aug 4. PMID: 35942707.","DOI":"10.1097\/MCC.0000000000000967"},{"issue":"6","key":"4021_CR15","doi-asserted-by":"publisher","first-page":"e0235059","DOI":"10.1371\/journal.pone.0235059","volume":"15","author":"Y Hatsuda","year":"2020","unstructured":"Hatsuda Y, Ishizaka T, Koizumi N, Yasui Y, Saito T, Maki S, Omotani S, Mukai J, Tachi T, Teramachi H, Myotoku M. Influence of analysis conditions for antimicrobial susceptibility test data on susceptibility rates. PLoS ONE. 2020;15(6):e0235059. https:\/\/doi.org\/10.1371\/journal.pone.0235059. PMID: 32574199; PMCID: PMC7310835.","journal-title":"PLoS ONE"},{"key":"4021_CR16","unstructured":"Hindler JA, Schuetz AN, June. CLSI Subcommittee on Antimicrobial Susceptibility Testing, CLSI AST News Update. Volume 7, Issue 1, 2022, https:\/\/clsi.org\/media\/rcqcsoad\/ast-news-update-volume-7-issue-1-june-2022.pdf"},{"key":"4021_CR17","doi-asserted-by":"publisher","unstructured":"Teitelbaum D, Elligsen M, Katz K, Lam PW, Lo J, MacFadden D, Vermeiren C, Daneman N. Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient. Clin Infect Dis. 2022;75(10):1763\u20131771. https:\/\/doi.org\/10.1093\/cid\/ciac256. PMID: 35380628.","DOI":"10.1093\/cid\/ciac256"},{"issue":"1","key":"4021_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jamda.2019.07.016","volume":"21","author":"MA Hughes","year":"2020","unstructured":"Hughes MA, Dosa DM, Caffrey AR, Appaneal HJ, Jump RLP, Lopes V, LaPlante KL. Antibiograms cannot be used interchangeably between acute care medical centers and affiliated nursing homes. J Am Med Dir Assoc. 2020;21(1):72\u20137. https:\/\/doi.org\/10.1016\/j.jamda.2019.07.016. Epub 2019 Sep 16. PMID: 31537479; PMCID: PMC7233453.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"4021_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1017\/ice.2020.395","volume":"42","author":"QT Vo","year":"2021","unstructured":"Vo QT, Klevens RM, Bolstorff B, Barton K, Cumming M, Blumenthal JA, Troppy TS, Gerth JM, DeMaria A. Utilization of cumulative antibiograms for public health surveillance: trends in Escherichia coli and Klebsiella pneumoniae susceptibility, Massachusetts, 2008\u20132018. Infect Control Hosp Epidemiol. 2021;42(2):169\u201375. Epub 2020 Aug 27. PMID: 32847644.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4021_CR20","doi-asserted-by":"publisher","unstructured":"Burillo A, Mu\u00f1oz P, Bouza E. Risk stratification for multidrug-resistant Gram-negative infections in ICU patients. Curr Opin Infect Dis. 2019;32(6):626\u2013637. https:\/\/doi.org\/10.1097\/QCO.0000000000000599. PMID: 31567570.","DOI":"10.1097\/QCO.0000000000000599"},{"key":"4021_CR21","doi-asserted-by":"publisher","unstructured":"Haider MH, McHugh TD, Roulston K, Arruda LB, Sadouki Z, Riaz S. Detection of carbapenemases blaOXA48-blaKPC-blaNDM-blaVIM and extended-spectrum-\u03b2-lactamase blaOXA1-blaSHV-blaTEM genes in Gram-negative bacterial isolates from ICU burns patients. Ann Clin Microbiol Antimicrob. 2022;21(1):18. https:\/\/doi.org\/10.1186\/s12941-022-00510-w. Erratum in: Ann Clin Microbiol Antimicrob. 2022;21(1):34. PMID: 35590320; PMCID: PMC9121598.","DOI":"10.1186\/s12941-022-00510-w"},{"issue":"4","key":"4021_CR22","doi-asserted-by":"publisher","first-page":"e02564","DOI":"10.1128\/AAC.02564-18","volume":"63","author":"L Puzniak","year":"2019","unstructured":"Puzniak L, DePestel DD, Srinivasan A, Ye G, Murray J, Merchant S, DeRyke CA, Gupta V. A combination antibiogram evaluation for Pseudomonas aeruginosa in respiratory and blood sources from intensive care unit (ICU) and Non-ICU settings in U.S. Hospitals. Antimicrob Agents Chemother. 2019;63(4):e02564\u201318. https:\/\/doi.org\/10.1128\/AAC.02564-18. PMID: 30917987; PMCID: PMC6496158.","journal-title":"Antimicrob Agents Chemother"},{"key":"4021_CR23","doi-asserted-by":"publisher","unstructured":"Henderson A, Paterson DL, Chatfield MD, Tambyah PA, Lye DC, De PP, Lin RTP, Chew KL, Yin M, Lee TH, Yilmaz M, Cakmak R, Alenazi TH, Arabi YM, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj SS, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke DFM, Runnegar NJ, Miyakis S, Walls G, Khamis MAI, Zikri A, Crowe A, Ingram PR, Daneman N, Griffin P, Athan E, Roberts L, Beatson SA, Peleg AY, Cottrell K, Bauer MJ, Tan E, Chaw K, Nimmo GR, Harris-Brown T, Harris PNA, MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin\/Tazobactam or Meropenem From the MERINO Study. Clin Infect Dis. 2021;73(11):e3842-e3850. https:\/\/doi.org\/10.1093\/cid\/ciaa1479. PMID: 33106863.","DOI":"10.1093\/cid\/ciaa1479"},{"issue":"2","key":"4021_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jiac.2021.10.022","volume":"28","author":"T Etani","year":"2022","unstructured":"Etani T, Mogami T, Yamaguchi S, Takeda T, Sugino T, Shimizu N, Noda Y, Nagai T, Nozaki S, Iida K, Naiki T, Ando R, Kawai N, Yasui T. Comparison of drug susceptibility between Escherichia coli detected in stool cultures of patients undergoing transrectal prostate needle biopsy and Escherichia coli in hospital-wide urine antibiograms. J Infect Chemother. 2022;28(2):343\u20136. https:\/\/doi.org\/10.1016\/j.jiac.2021.10.022. Epub 2021 Nov 5. PMID: 34750049.","journal-title":"J Infect Chemother"},{"issue":"1","key":"4021_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","volume":"20","author":"G winKaram","year":"2016","unstructured":"winKaram G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):136. https:\/\/doi.org\/10.1186\/s13054-016-1320-7. PMID: 27329228; PMCID: PMC4916531.","journal-title":"Crit Care"},{"key":"4021_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/IDR.S386311","volume":"16","author":"C Wu","year":"2023","unstructured":"Wu C, Lu J, Ruan L, Yao J. Tracking epidemiological characteristics and risk factors of Multi-Drug resistant Bacteria in intensive care units. Infect Drug Resist. 2023;16:1499\u2013509. https:\/\/doi.org\/10.2147\/IDR.S386311. PMID: 36945682; PMCID: PMC10024905.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"4021_CR27","doi-asserted-by":"publisher","first-page":"e0302053","DOI":"10.1371\/journal.pone.0302053","volume":"19","author":"M Shawa","year":"2024","unstructured":"Shawa M, Paudel A, Chambaro H, Kamboyi H, Nakazwe R, Alutuli L, Zorigt T, Sinyawa T, Samutela M, Chizimu J, Simbotwe M, Hayashida K, Nao N, Kajihara M, Furuta Y, Suzuki Y, Sawa H, Hang\u2019ombe B, Higashi H. Trends, patterns and relationship of antimicrobial use and resistance in bacterial isolates tested between 2015\u20132020 in a National referral hospital of Zambia. PLoS ONE. 2024;19(4):e0302053. https:\/\/doi.org\/10.1371\/journal.pone.0302053. PMID: 38625961; PMCID: PMC11020921.","journal-title":"PLoS ONE"},{"issue":"1","key":"4021_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13756-022-01203-x","volume":"11","author":"A Munting","year":"2022","unstructured":"Munting A, Damas J, Viala B, Prod\u2019hom G, Guery B, Senn L. Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital. Antimicrob Resist Infect Control. 2022;11(1):165. https:\/\/doi.org\/10.1186\/s13756-022-01203-x. PMID: 36585736; PMCID: PMC9805013.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"4021_CR29","doi-asserted-by":"publisher","first-page":"16876","DOI":"10.1038\/s41598-021-95873-z","volume":"11","author":"R Sommerstein","year":"2021","unstructured":"Sommerstein R, Damonti L, Marschall J, Harbarth S, Gasser M, Kronenberg A, Buetti N. Distribution of pathogens and antimicrobial resistance in ICU-bloodstream infections during hospitalization: a nationwide surveillance study. Sci Rep. 2021;11(1):16876. https:\/\/doi.org\/10.1038\/s41598-021-95873-z. PMID: 34413340; PMCID: PMC8376881.","journal-title":"Sci Rep"},{"issue":"1","key":"4021_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13643-022-02152-7","volume":"12","author":"J Acam","year":"2023","unstructured":"Acam J, Kuodi P, Medhin G, Makonnen E. Antimicrobial prescription patterns in East Africa: a systematic review. Syst Reviews. 2023;12(1):18. https:\/\/doi.org\/10.1186\/s13643-022-02152-7.","journal-title":"Syst Reviews"},{"issue":"5","key":"4021_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/17460441.2019.1588880","volume":"14","author":"VM Chernov","year":"2019","unstructured":"Chernov VM, Chernova OA, Mouzykantov AA, Lopukhov LL, Aminov RI. Omics of antimicrobials and antimicrobial resistance. Expert Opin Drug Discov. 2019;14(5):455\u201368. Epub 2019 Mar 19. PMID: 30884978.","journal-title":"Expert Opin Drug Discov"},{"key":"4021_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jgar.2021.10.025","volume":"29","author":"L Chelkeba","year":"2022","unstructured":"Chelkeba L, Melaku T. Epidemiology of Staphylococci species and their antimicrobial-resistance among patients with wound infection in Ethiopia: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2022;29:483\u201398. https:\/\/doi.org\/10.1016\/j.jgar.2021.10.025. Epub 2021 Nov 18. PMID: 34801740.","journal-title":"J Glob Antimicrob Resist"},{"issue":"8","key":"4021_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/14740338.2022.2106368","volume":"21","author":"B Godman","year":"2022","unstructured":"Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C, Kgatlwane J, Mwita JC, Patrick O, Niba LL, Amu AA, Oguntade RT, Alabi ME, Ncube NBQ, Sefah IA, Acolatse J, Incoom R, Guantai AN, Oluka M, Opanga S, Chikowe I, Khuluza F, Chiumia FK, Jana CE, Kalemeera F, Hango E, Fadare J, Ogunleye OO, Ebruke BE, Meyer JC, Massele A, Malande OO, Kibuule D, Kapona O, Zaranyika T, Bwakura-Dangarembizi M, Kujinga T, Saleem Z, Kurdi A, Shahwan M, Jairoun AA, Wale J, Brink AJ. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future. Expert Opin Drug Saf. 2022;21(8):1089\u2013111. https:\/\/doi.org\/10.1080\/14740338.2022.2106368. Epub 2022 Aug 30. PMID: 35876080.","journal-title":"Expert Opin Drug Saf"},{"key":"4021_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jgar.2022.11.016","volume":"32","author":"EH Haindongo","year":"2023","unstructured":"Haindongo EH, Ndakolo D, Hedimbi M, Vainio O, Hakanen A, Vuopio J. Antimicrobial resistance prevalence of Escherichia coli and Staphylococcus aureus amongst bacteremic patients in Africa: a systematic review. J Glob Antimicrob Resist. 2023;32:35\u201343. Epub 2022 Dec 14. PMID: 36526264.","journal-title":"J Glob Antimicrob Resist"},{"key":"4021_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijid.2020.08.057","volume":"100","author":"P Veepanattu","year":"2020","unstructured":"Veepanattu P, Singh S, Mendelson M, Nampoothiri V, Edathadatil F, Surendran S, Bonaconsa C, Mbamalu O, Ahuja S, Birgand G, Tarrant C, Sevdalis N, Ahmad R, Castro-Sanchez E, Holmes A, Charani E. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK. Int J Infect Dis. 2020;100:278\u201382. Epub 2020 Aug 27. PMID: 32860949; PMCID: PMC7449941.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4021_CR36","doi-asserted-by":"publisher","first-page":"e0136621","DOI":"10.1128\/jcm.01366-21","volume":"60","author":"A Viloria Winnett","year":"2022","unstructured":"Viloria Winnett A, Srinivasan V, Davis M, Vijayan T, Uslan DZ, Garner OB, de St Maurice A. The path of more resistance: a comparison of National healthcare safety network and clinical laboratory standards Institute criteria in developing cumulative antimicrobial susceptibility test reports and institutional antibiograms. J Clin Microbiol. 2022;60(2):e0136621. Epub 2021 Dec 1. PMID: 34851679; PMCID: PMC8849356.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04021-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:11:23Z","timestamp":1747199483000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04021-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5139383\/v1","asserted-by":"object"}]},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No experimental protocols were applied, we only collected the retrospective data to develop the Antibiogram from the lab records. The study was approved by the Institutional Review board Alribat University Hospital, Police Headquarters Hospitals and treatment centers on June 2022, Ref: 01-2022. All methods were carried out in accordance with relevant guidelines and regulations (declarations of Helsinki). Informed consents were obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}